CAS 252977-51-8

7-(1,1-Dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine

Description:

The chemical substance known as 7-(1,1-Dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine, with the CAS number 252977-51-8, is a complex organic compound characterized by its multi-ring structure that incorporates both triazole and pyridazine moieties. This compound features a tert-butyl group, which contributes to its hydrophobic properties, and an ethyl-substituted triazole that may enhance its biological activity. The presence of a fluorophenyl group suggests potential interactions with biological targets, possibly influencing its pharmacological profile. The compound's unique structure may confer specific reactivity and solubility characteristics, making it of interest in medicinal chemistry, particularly in the development of agrochemicals or pharmaceuticals. Its synthesis and characterization would typically involve advanced organic chemistry techniques, and its potential applications could be explored through biological assays to assess efficacy and safety. Overall, this compound exemplifies the intricate design often found in modern chemical entities aimed at specific therapeutic or functional outcomes.

Formula: C₂₀H₂₂FN₇O

InChI: InChI=1S/C20H22FN7O/c1-5-27-17(22-12-23-27)11-29-19-14(20(2,3)4)10-16-24-25-18(28(16)26-19)13-8-6-7-9-15(13)21/h6-10,12H,5,11H2,1-4H3

InChI key: InChIKey=QKIWQBLNTSQOLY-UHFFFAOYSA-N

SMILES: O(CC=1N(CC)N=CN1)C2=NN3C(=NN=C3C=C2C(C)(C)C)C4=C(F)C=CC=C4

Synonyms:

• MK 0777
• 1,2,4-Triazolo[4,3-b]pyridazine, 7-(1,1-dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-
• TPA 023
• 7-(1,1-Dimethylethyl)-6-[(1-ethyl-1H-1,2,4-triazol-5-yl)methoxy]-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine
• 7-tert-butyl-6-[(2-ethyl-1,2,4-triazol-3-yl)methoxy]-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine
• 7-(tert-butyl)-6-((1-ethyl-1H-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazine

TPA 023

CAS: 252977-51-8

TPA 023

Purity: ≥98%

Molecular weight: 395.43g/mol

Ref: 54-BUP05186

7-(TERT-BUTYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-[1,2,4]TRIAZOLO[4,3-B]PYRIDAZINE

CAS: 252977-51-8

Purity: 95.0%

Molecular weight: 395.4419860839844

Ref: 10-F529134

TPA 023

CAS: 252977-51-8

TPA 023 is a drug that is used in the treatment of anxiety and depression. It has been found to bind with benzodiazepine binding sites, which are receptors that are located on the surface of neurons. These receptors are activated by benzodiazepines, which can cause sedation and relieve anxiety. TPA 023 binds with high affinity to the α1 subunit of GABA-A receptor, which is responsible for mediating neuronal inhibition. TPA 023 has been shown to inhibit the release of epidermal growth factor (EGF) in cultured cells, suggesting that it may be useful in treating skin conditions such as psoriasis. It also inhibits the activity of lorazepam, a nonselective GABA-A receptor agonist.

Formula: C₂₀H₂₂FN₇O

Purity: Min. 95%

Molecular weight: 395.43 g/mol

Ref: 3D-CKA97751

TPA 023

CAS: 252977-51-8

TPA 023 is a selective agonist of GABAA α2/α3 subtype (Kis = 0.19 - 0.41 nM).

Formula: C₂₀H₂₂FN₇O

Purity: 99.75%

Color and Shape: Solid

Molecular weight: 395.43

Ref: TM-T17144